SAN DIEGO, March 28, 2024 /PRNewswire/ Heron Therapeutics, Inc. , a commercial-stage biotechnology company, today announced that Craig Collard, Chief Executive Officer of Heron, will participate.
/PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results.
Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO, Jan. 7, 2024 /PRNewswire/ Heron Therapeutics, Inc. , a commercial-stage biotechnology company, today announced that it has entered into a five-year distributor partnership with.